SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039043
Filing Date
2023-05-12
Accepted
2023-05-12 16:21:56
Documents
72
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_bioessen.htm   iXBRL 10-Q 472349
2 CERTIFICATION f10q0323ex31-1_bioessence.htm EX-31.1 8412
3 CERTIFICATION f10q0323ex31-2_bioessence.htm EX-31.2 8024
4 CERTIFICATION f10q0323ex32-1_bioessence.htm EX-32.1 4918
5 CERTIFICATION f10q0323ex32-2_bioessence.htm EX-32.2 5503
6 GRAPHIC image_001.jpg GRAPHIC 16220
  Complete submission text file 0001213900-23-039043.txt   3878155

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cik00001723059-20230331.xsd EX-101.SCH 71146
8 XBRL CALCULATION FILE cik00001723059-20230331_cal.xml EX-101.CAL 36984
9 XBRL DEFINITION FILE cik00001723059-20230331_def.xml EX-101.DEF 217336
10 XBRL LABEL FILE cik00001723059-20230331_lab.xml EX-101.LAB 465530
11 XBRL PRESENTATION FILE cik00001723059-20230331_pre.xml EX-101.PRE 227249
66 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_bioessen_htm.xml XML 334689
Mailing Address 8 STUDEBAKER DRIVE IRVINE CA 92618
Business Address 8 STUDEBAKER DRIVE IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56263 | Film No.: 23916135
SIC: 2834 Pharmaceutical Preparations